SCHEMBL3469241

SCHEMBL3469241

COc1ccc(O)c(NC(=O)c2cc(-c3c[nH]nc3C3CCN(C)CC3)cnc2N)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKBKE Q14164 2/20 0.40
TBK1 Q9UHD2 2/20 0.40
LRRK2 Q5S007 1/20 0.39
CHRNA7 P36544 2/20 0.38
BMPR1B O00238 3/20 0.38
BMPR1A P36894 3/20 0.38
ACVRL1 P37023 3/20 0.38
ACVR1 Q04771 3/20 0.38
AXL P30530 6/20 0.38
MERTK Q12866 6/20 0.38
CLK2 P49760 1/20 0.37
CLK3 P49761 1/20 0.37
DYRK1A Q13627 1/20 0.37
TGFBR1 P36897 2/20 0.37
GSK3B P49841 1/20 0.37
PIK3C3 Q8NEB9 2/20 0.36
HDAC1 Q13547 1/20 0.36
IL2 P60568 1/20 0.36
MAP4K1 Q92918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3469184 0.94 IKBKE (0.41) IKBKETBK1LRRK2CHRNA7BMPR1B
SCHEMBL3469125 0.83 CHRNA7 (0.43) IKBKETBK1CHRNA7BMPR1BBMPR1A
SCHEMBL2497147 0.81 BMPR1B (0.40) LRRK2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL2388397 0.80 AXL (0.56) IKBKETBK1AXLMERTKDYRK1A
SCHEMBL3469349 0.79 BMPR1B (0.39) LRRK2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL3469290 0.78 BMPR1B (0.38) LRRK2BMPR1BBMPR1AACVRL1ACVR1
Hydrochloric Acid SCHEMBL3469292 0.78 BMPR1B (0.38) LRRK2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL3469171 0.77 CHRNA7 (0.40) IKBKETBK1CHRNA7BMPR1BBMPR1A
SCHEMBL2387892 0.75 MERTK (0.57) IKBKETBK1AXLMERTK
SCHEMBL3470462 0.72 LRRK2 (0.51) LRRK2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP disclosed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO disclosed